Recent Articles

• 
  MedTech

  Celltrion Internalizes Hyaluronidase SC Formulation Technology

  Celltrion is moving to expand its product lineup of subcutaneous (SC) formulation drugs in earnest. The SC formulation is a method of injecting a drug directly into the subcutaneous tissue, namely the fat layer beneath the skin. It is characterized as a formulation that can improve treatment conveni

  2026.02.02
• 
  MedTech

  Saliva Test Enables Early Detection of Brain Diseases

  The Korea Institute of Materials Science (KIMS) and a Korea University research team have developed a technology that can enable early diagnosis of major neurological disorders such as epilepsy, Parkinson’s disease, and schizophrenia using only a small amount of saliva. From left: Dr. Lee Min-young

  2026.02.02
• 
  Public Health

  Hair Loss Recognized as Disease from Follicle Damage

  In recent academic discourse, there is growing recognition of hair loss as a disease of modern people. Getty Images Bank After President Lee Jae-myung stated during the Ministry of Health and Welfare’s year-end 2025 policy briefing that “hair loss is a matter of survival,” controversy has reignited

  2026.02.02
• 
  MedTech

  OLED “Hair-Loss Cap” Claims 92% Cell Aging Cut

  Instead of heavy, rigid helmet-type hair-loss treatment devices, an organic light-emitting diode (OLED)-based hair-loss treatment device that can be worn in everyday life like a “cap” is expected to be introduced. On 1 February, KAIST announced that a research team led by Professor Choi Kyung-cheol

  2026.02.01
• 
  Global Expansion

  Daewoong Pharma Secures Nabota Export Deal to Mexico

  Daewoong Pharmaceutical announced on the 30th that it has signed an export contract worth KRW 29.5 billion for Nabota in the Mexican market with Moksha8. Moksha8 is Daewoong Pharmaceutical’s partner company for the Latin American region.With this contract, Daewoong Pharmaceutical’s Nabota has succes

  2026.01.30
• 
  Pharmaceutical R&D

  GC Cell Publishes 9-Year ImmunCell-LC Data in Journal

  GC Cell announced on the 30th that the results of a long-term clinical study of its immune cell therapy “Immuncell-LC Inj.” in patients with hepatocellular carcinoma have been published in an international academic journal.According to GC Cell, the study integrated approximately nine years of long-t

  2026.01.30
• 
  의학 / 디지털헬스케어

  GD Corporation, Daegu Health College Sign Sleep Tech MOU

  GD Corporation CEO Kim Jung-sung (third from left) and Daegu Health College Executive Vice President Kim Young-joon take a commemorative photo after signing a memorandum of understanding. Photo provided by GD Corporation Sleep lifestyle brand company GD Corporation Co., Ltd. (CEO Kim Jung-sung) anno

  2026.01.30
• 
  AI Healthcare

  Helios Outlines AI Home Healthcare Strategy in Aging Korea

  Helios CEO Na Jeong-uk emphasizes the strategy of ‘AI Home Healthcare’ and the urgency of preventive medicine. Photo provided by Helios Helios Co., Ltd. announced that it presented healthcare management measures for an aging society at the “2026 AX Forum – AI for a Safer Korea Forum” held on the 12t

  2026.01.29
• 
  Healthcare / TECH

  Apple Watch to Offer Hypertension Alerts in Korea

  Provided by Apple Apple has launched the Apple Watch high blood pressure notification feature in Korea. The feature had previously been available only to users in certain countries, including the United States and the European Union (EU), but Korean users can now use it following recent approval by

  2026.01.28
• 
  AI Healthcare

  Ransik Wins Approval to Launch Cybionics GS1 CGM in Korea

  Image provided by Ransik Digital healthcare startup Ransik announced that it has completed the regulatory approval procedures for the domestic launch of “GS1,” a product from global continuous glucose monitoring (CGM) company SIBIONICS. Based on this approval, Ransik plans to begin full-scale prepar

  2026.01.28